1. Chopra HK
2. Parashar Satish K
3. Mangla PK

9789352706969

10.5005/jp/books/18183_97

1/e

2019

10

1. Moolchand Medcity Hospital, New Delhi, India, Medanta Moolchand Heart Institute, Moolchand Medcity, New Delhi, India, Medanta Moolchand Heart Institute, Moolchand Medcity; World Wellness Foundation, WHA; AHA, Medanta Moolchand Heart Institute; Moolchand Medcity; World Wellness Foundation, WHA; CSI & IAE; IHJ, JIAE, Medanta Moolchand Heart Institute; Moolchand Medcity; World Wellness Foundation, WHA, Medanta Moolchand Heart Institute, New Delhi, India; CME, Moolchand Medcity, World Wellness, Foundation and WHA; AHA; CSI and IAE; IHJ and JIAE, IAE-2017, CSI-2015; World Wellness Foundation, Country Head, American Heart Association; Medanta Moolchand Heart Institute; Health Committee, SCOPE, Tata Sky FAM Health, New Delhi, India, IAE- 2017, CSI -2015; World Wellness Foundation; American Heart Association; Moolchand Medcity; Physician Governing Body, CME, COP Moolchand Medcity, New Delhi, India, IAE- 2017, CSI -2015; World Wellness Foundation; Physician Governing Body, CME, COP Moolchand Medcity, New Delhi, India
2. Metro Hospitals and Heart Institute, New Delhi, India, Metro Hospitals and Heart Institute, New Delhi and Noida, India, Metro Heart Institute, New Delhi, India, Metro Group of Hospitals and Heart Institute, Delhi, India, Metro Hospital and Heart Institute, New Delhi, India, Noninvasive Cardiac Laboratory at Metro Group of Hospitals and Heart Institute, New Delhi, India; Ministry of Health and Family Welfare Government of India, Noninvasive Cardiac Laboratory at Metro Group of Hospitals and Heart Institute, New Delhi, India; Distinguished Service Award by Ministry of Health and Family Welfare, Government of India
3. Moolchand Medcity, New Delhi, India

Echocardiographic navigation, pulmonary embolism, deep vein thrombosis, acute pulmonary embolism, APE, right ventricular dysfunction, RVD, pathophysiology, predisposing factor, diagnosis, pulmonary arterial hypertension, PAH